Skip to Content

SCTOD Requirements

Main Content

The Stem Cell Therapeutic and Research Act of 2005 requires US transplant centers to submit outcomes data on all allogeneic transplants, both related and unrelated, when either the donor or the recipient resides in the United States (US), or if the collection or infusion takes place in a US center. The contract to manage this outcomes database, named the Stem Cell Therapeutic Outcomes Database (SCTOD), was awarded to CIBMTR in 2006. 

SCTOD reporting requirements

SCTOD reporting requirements vary depending on a center’s location, the origin of the transplanted graft, and the type of transplant performed:
Recipient data are considered part of the SCTOD if they meet one of the following criteria:

  • Allogeneic transplant occurs at a US transplant center
  • Stem cell collection is performed within the US
  • Cord blood unit is obtained from a cord blood bank within the US

Recipient data are not considered part of the SCTOD if they meet one of the following criteria:

  • Recipient receives an autologous transplant
  • Transplant does not occur in the US and the stem cells are collected outside of the US
  • Cord blood unit is obtained from a cord blood bank outside of the US and the transplant occurs outside of the US

Implementation of SCTOD

Two important initiatives undertaken by CIBMTR to help transplant centers meet SCTOD data collection and submission requirements include:

  • FormsNet - An electronic data collection application
  • AGNIS® - An automated system to electronically exchange data between transplant center databases and FormsNet